π¬ Current Disease Focus:
Task Progress: 0%
π₯ Active Problem Solvers
0
π Experts collaborating globally
β‘ Current Task Assignment
𧬠Genetic Analysis
π Matching experts to specific tasks
π Resource Allocation by Research Phase:
π Data Analysis
π§ͺ Experimental Design
π¬ Clinical Trials
π Treatment Development
The main objectives were: 1) To determine the efficacy of both cevimeline a...
Status
Completed
Location
University of Kentucky Orofacial Pain Center College of Dentistry
Start Date
2009-01
Trial ID
NCT01690052
Treatments Being Tested
The aim of the present study is to develop a measurement protocol for optim...
Status
Unknown
Location
Department of Clinical Pharmacology, Medical University of Vienna
Start Date
2016-04-20
Trial ID
NCT02865473
Treatments Being Tested
Glaucoma is the leading cause of irreversible blindness worldwide. Although...
Status
Unknown
Location
Multiple Locations
Start Date
2022-05-01
Trial ID
NCT05352854
Treatments Being Tested
Clinical studies of lumacaftor + ivacaftor (combo therapy) produced better ...
Status
Completed
Location
Stanford Hospital and Clinics
Start Date
2015-07-31
Trial ID
NCT02310789
Treatments Being Tested
The purpose of the GenderBOLD study is to shed light on the mechanisms resp...
Status
Completed
Location
CHUV, nephrology service
Start Date
2017-05-30
Trial ID
NCT04085094
This is a Multicenter, Randomized, Double-Masked, Placebo-Controlled, Paral...
Status
Completed
Location
Glaukos Investigator
Start Date
2022-01-03
Trial ID
NCT05119920
Purpose: To determine the efficacy of treatment with latanoprost in combina...
Status
Unknown
Location
New York Eye and Ear Infirmary
Start Date
2000-08
Trial ID
NCT00804115
Treatments Being Tested
Safety and Efficacy of Pilocarpine, Brimonidine, Oxymetazoline, Hyaluronic ...
Status
Unknown
Location
Optall Vision
Start Date
2021-08-14
Trial ID
NCT05006911
Treatments Being Tested
Students at the School of Medicine Greenville will be asked to participate ...
Status
Completed
Location
Prisma Health
Start Date
2022-04-01
Trial ID
NCT05238233
Treatments Being Tested
This is a 4-visit, multi-center, randomized, double-masked, vehicle-control...
Status
Completed
Location
Orasis Investigative Site
Start Date
2020-10-26
Trial ID
NCT04599972